|[February 21, 2013]
Kinetigen to Showcase Pharmacokinetics Expertise at ASCPT Annual Meeting and Exhibition
RESEARCH TRIANGLE PARK, N.C. --(Business Wire)--
Kinetigen, Inc., a specialty pharmaceutical consulting firm with global
reach, will be exhibiting and sharing its in-depth knowledge of how to
use Pharmacokinetics (PK) more efficiently at the American Society for
Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting in
Indianapolis, March 5-8.
Pharmacokinetics is about capturing the right information at the right
time, yet insufficient planning, execution and analysis around PK can
lead to poor data, adding costs and delays to drug development.
Kinetigen specializes in translating complex PK issues into robust and
actionable advice for rational drug development. Accordingly, companies
are realizing cost-effective results by our consultants providing the
right mix of substance and usability in pharmacokinetics.
"Kinetigen's dedication to excellence in pharmacokinetics continues to
pay ividends for our clients," said Geoffrey Banks, Ph.D., company CEO.
"We look forward to sharing our vision with attendees at ASCPT about how
pharmacokinetic analyses can be conducted to save time and money in drug
development," he explained.
Kinetigen's focus on PK means that its team of industry-leading
consultants provides better interpretation of PK data and superior
advice for clients, Dr. Banks explained, "Kinetigen aims to actively
reduce risk in drug development and increase the value of clinical
pharmacology and PK investigations by applying proven strategies."
About Kinetigen, Inc.
Kinetigen, Inc. is a clinical pharmacology consulting firm specializing
in pharmacokinetics. Fast becoming the pharmaceutical industry's go-to
resource for pharmacokinetics, Kinetigen gives pharmaceutical companies
and CROs rare access to a hands-on team of leading clinical pharmacology
and pharmacokinetics professionals experienced in many different
therapeutic areas. We embrace the notion that simplicity and clarity
lead to good decisions by taking complex pharmacokinetic principals and
making them understandable and usable for common sense drug development.
Kinetigen's flexible business structure enables us to integrate with our
clients and help them maximize the potential of clinical pharmacology
studies and pharmacokinetics analyses to pave the way toward marketing
For more information visit www.kinetigen.com.
[ Back To TMCnet.com's Homepage ]